regulatory
confidence high
sentiment negative
materiality 0.70
Alaunos Therapeutics, Inc. (TCRT): Nasdaq/NYSE listing notice — Alaunos Therapeutics receives Nasdaq deficiency notice for bid price below $1.00
Alaunos Therapeutics, Inc.
- Nasdaq notified Alaunos on Jan 4, 2023 that TCRT bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 days (until July 3, 2023) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by July 3, may seek 180-day extension by transferring to Nasdaq Capital Market.
- No assurance of regaining compliance; delisting remains a risk.